Actively Recruiting
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Led by Ulsan University Hospital · Updated on 2026-02-12
414
Participants Needed
5
Research Sites
26 weeks
Total Duration
On this page
Sponsors
U
Ulsan University Hospital
Lead Sponsor
N
National Cancer Center, Korea
Collaborating Sponsor
AI-Summary
What this Trial Is About
Researchers are assessing the clinical effectiveness and cost-efficiency of a digital health platform designed to help cancer patients manage chemotherapy side effects. This platform combines symptom reporting software called Smart Cancer Care Plus with a standardized telenursing program. The study focuses on adults diagnosed with early or advanced gastric, lung, breast, or colon cancer who are beginning their first cycle of chemotherapy with a new anticancer drug. Participants are randomly assigned to one of three groups: standard care without the digital platform or telenursing, use of Smart Cancer Care Plus alone, or use of Smart Cancer Care Plus combined with standardized telenursing. The telenursing intervention includes structured telephone counseling triggered by severe symptoms or missed weekly symptom reports to ensure timely follow-up and support. Over 12 weeks, researchers will evaluate quality of life using a cancer-specific questionnaire. Additional assessments over six months will examine self-management abilities, overall health ratings, adherence to symptom reporting, chemotherapy adherence, healthcare use, functional status, symptom severity, and satisfaction with the system. Participants will be monitored regularly through digital tools and phone support to track and manage chemotherapy-related side effects throughout the study duration.
CONDITIONS
Brief Title
Evaluation of the Effectiveness of Managing Chemotherapy Side Effects Using ePRO and a Standardized Telenursing Program for Cancer Patients
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adults aged 19 years or older
- Diagnosed with early or advanced gastric, lung, breast, or colon cancer
- Starting first-cycle chemotherapy with a new anticancer agent
- Able to use a smartphone without difficulty
- Willing to provide informed consent to participate in the study
You will not qualify if you...
- Difficulty communicating due to cognitive, visual, or hearing impairments
- Cannot read, write, or understand Korean
- Deemed inappropriate for participation by the investigators
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - 12 weeks
Participants use either standard care, Smart Cancer Care Plus for symptom monitoring, or Smart Cancer Care Plus combined with standardized telenursing for managing chemotherapy side effects during their chemotherapy treatment.
Weekly symptom reporting and monitoring visits
Duration - 6 months
Participants are assessed for self-management, overall health, chemotherapy adherence, healthcare utilization, functional status, symptom severity, and satisfaction for up to 6 months after treatment.
Periodic assessments during follow-up
Trial Site Locations
Total: 5 locations
1
Kosin University Gospel Hospital
Busan, South Korea
Actively Recruiting
2
National Cancer Center, Korea
Goyang, South Korea
Actively Recruiting
3
Gachon University Gil Medical Center
Incheon, South Korea
Not Yet Recruiting
4
Gyeongsang National University
Jinju, South Korea
Actively Recruiting
5
Ulsan University Hospital
Ulsan, South Korea
Actively Recruiting
Research Team
M
Minseon Song, bachelor's degree
S
Somin Joen, bachelor's degree
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here